Literature DB >> 12464204

Carcinosarcoma of the parotid gland with epithelial-myoepithelial carcinoma and pleomorphic sarcoma components.

S Manuel1, A Mathews, K Chandramohan, M Pandey.   

Abstract

We report a case of true malignant mixed tumour (carcinosarcoma) of the parotid gland with epithelial-myoepithelial carcinoma and pleomorphic sarcomatous components in a 68-year-old woman. The pleomorphic sarcomatous component behaved aggressively with lymph node and distant metastases. The biological behaviour of the individual components in a malignant mixed tumour makes it difficult to diagnose. We could find no previous report of epithelial-myoepithelial carcinoma as a component of a carcinosarcoma of the parotid.

Entities:  

Mesh：

Year:  2002        PMID： 12464204     DOI： 10.1016/s0266435602002462

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN： 0266-4356            Impact factor:   1.651


  5 in total

1.  Sarcomatoid salivary duct carcinoma of the oral cavity.

Authors:  Fumio Ide; Kenji Mishima; Ichiro Saito
Journal:  Virchows Arch       Date:  2003-11       Impact factor: 4.064

Review 2.  "Dedifferentiation" and high-grade transformation in salivary gland carcinomas.

Authors:  Toshitaka Nagao
Journal:  Head Neck Pathol       Date:  2013-07-03

3.  Malignant myoepithelioma of the maxilla posing a diagnostic dilemma.

Authors:  Sheeraz Badal; Syed Ahmed; Padmakar S Patil; Afreen Badal
Journal:  Natl J Maxillofac Surg       Date:  2013-07

4.  Giant Parotid Pleomorphic Adenoma with Atypical Histological Presentation and Long-Term Recurrence-Free Follow-Up after Surgery: A Case Report and Review of the Literature.

Authors:  Mohammed AlKindi; Sundar Ramalingam; Lujain Abdulmajeed Hakeem; Manal A AlSheddi
Journal:  Case Rep Dent       Date:  2020-08-31

5.  Epithelial-myoepithelial carcinoma with high-grade transformation of parotid gland: A case report and literature review.

Authors:  Bowen Li; Hongyu Yang; Xia Hong; Yufan Wang; Feng Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.